CardioMEMS, Inc. wins 2012 Intel Innovation Award

              CardioMEMS, Inc. wins 2012 Intel Innovation Award

PR Newswire

ATLANTA, Dec. 11, 2012

ATLANTA, Dec. 11, 2012 /PRNewswire/ --CardioMEMS, Inc., an Atlanta-based
medical technology company that has developed and is commercializing a
proprietary wireless sensing and communication technology for the human body,
announced today that it has been honored as the 2012 recipient of the Intel
Innovation Award. Founder and CEO Jay Yadav, M.D., was presented with the
award on December 4^th during the annual Health IT Leadership Summit held at
the historic Fox Theatre in Atlanta, GA.

"CardioMEMS unites two areas where Georgia has strengths – health IT and
medical devices," said David B. Hartnett, Vice President, Bioscience & Health
IT Development, Metro Atlanta Chamber. "This truly innovative company
integrates these two disciplines to create advanced technology that holds huge
promise for heart failure patients. We are proud that they are part of the
Atlanta healthcare community, and look forward to watching their continued
success."

"It was a challenging decision, given the high level of competition for this
award," said Dan Rivera, Area Director, Intel Americas. "Ultimately,
CardioMEMS was chosen as the winner based on its ground-breaking technology
and novel use of health IT to reduce the burden on our healthcare system."

"We are honored to be recognized by Intel, a leader in innovative solutions,"
said Dr. Yadav. "This is a testament to the extraordinary efforts of the
CardioMEMS team to generate precise, timely, actionable information to address
the tremendous burden heart failure places on the U.S. healthcare system and
on patients suffering from this debilitating disease. We are fortunate to
have the considerable support of the Technology Association of Georgia, the
Metro Atlanta Chamber and the Georgia Department of Economic Development as we
continue to bring CardioMEMS' revolutionary technology to market."

About CardioMEMS, Inc.
CardioMEMS is a medical device company that has developed and is
commercializing proprietary wireless sensing and communication technology for
the human body. The Company's technology platform is designed to improve the
management of severe chronic cardiovascular diseases such as aneurysms, heart
failure and hypertension. CardioMEMs miniature wireless sensors can be
implanted using minimally-invasive techniques and transmit cardiac output,
blood pressure and heart rate data which are critical to the management of
patients. The sensors are designed to be permanently implanted into the heart
and blood vessels due to their small size, durability and lack of wires and
batteries. Using radiofrequency energy, the sensors transmit real-time data to
external electronic readers, which then communicate this information to the
patient's physician. The Company developed this technology based on the belief
that frequent, on-demand, real-time monitoring of vital information enables
proactive patient management, which holds the promise of reducing
hospitalizations, improving a patient's quality of life and delivering more
efficient and cost effective health care. More information about the
CardioMEMs is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that
express beliefs, expectations or hopes regarding future occurrences or
anticipated outcomes are forward-looking statements. A number of risks and
uncertainties such as risks associated with product development and
commercialization efforts, expected timing or results of any clinical trials,
ultimate clinical outcome and perceived or actual advantages of the Company's
products, market and physician acceptance of the products, intellectual
property protection, and competitive offerings could cause actual events to
adversely differ from the expectations indicated in these forward looking
statements.

CardioMEMS, Champion and the CardioMEMS logo are registered trademarks of
CardioMEMS, Inc.

Caution: The Champion Heart Failure Monitoring System is an investigational
device limited by federal law to investigational use.

SOURCE CardioMEMS, Inc.

Website: http://www.cardiomems.com
Contact: Dan Bauer, Chief Financial Officer, CardioMEMS, Inc.,
+1-404-651-2300, dbauer@cardiomems.com